Pancreatitis Due to De Novo PRSS1 Pathogenic Mutations: The Ambry Genetics Experience

•PRSS1-related HP due to de novo alterations is rare; we identified this in less than 0.05% of cases (2/9,000 samples).

•Parental testing and genetic counseling should be considered for accurate risk assessment and appropriate clinical follow-up.

 

  • Title: Pancreatitis Due to De Novo PRSS1 Pathogenic Mutations: The Ambry Genetics Experience
  • Authors: Melissa Samons; Brissa Martin; Jing Wang
  • Collaborators:
  • Conference: PancreasFest
  • Date: Thursday, Jul 27, 2017 4:45pm-5:30pm